Cellectis Publishes Social Media Community Guidelines

CELLECTIS

Biotechnology company Cellectis has officially published its community guidelines for its social media channels. These guidelines cover the company's public platforms, including Twitter and LinkedIn, and are designed to encourage open interaction with the public while ensuring compliance with regulations and corporate ethics.

The guidelines aim to create a respectful and informative discussion environment. Cellectis emphasizes that all comments and posts must be made respectfully and stay on topic. Any posts that violate these guidelines, are inappropriate, or serve promotional purposes will be removed. As a regulated pharmaceutical company, Cellectis may need to remove discussions relating to product use, approved or unapproved, to comply with regulatory requirements.

Cellectis values transparency and open communication with its community. The company strives to answer questions and share insights about the company and its industry. At the same time, the company reminds users that comments posted by users on social media channels do not necessarily reflect the views of Cellectis or its owners, but are the responsibility of the individual posting them.

The company reserves the right to update its social media guidelines periodically and encourages users to check them regularly. This approach aims to balance the need for free exchange of information with adherence to strict medical and legal requirements.